We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

001040:KRXCJ Corporation Analysis

Data as of 2026-06-14 - not real-time

₩174,500.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CJ Corporation is trading at 174,500 KRW, notably below its 20‑day (177,350 KRW), 50‑day (195,726 KRW) and 200‑day (186,532 KRW) simple moving averages, indicating a short‑term lag despite a neutral overall trend. The RSI sits at 44.9, suggesting neither overbought nor oversold conditions, while the MACD histogram has turned positive (≈+786), giving a bullish signal that could spark a modest rebound toward the 159,300 KRW support level. Market sentiment is extremely optimistic, reflected by a Fear & Greed Index of 89.86 (Extreme Greed) and an implied upside of roughly 38% toward a 240,000 KRW target.
On the fundamentals side, the company delivers solid top‑line growth (8% YoY revenue increase) but struggles with thin profitability (0.33% net margin) and a heavy debt load (debt‑to‑equity 115). The forward P/E of 9.1 is well below the industry average of 30.6, and the price‑to‑sales ratio of 0.13 points to a potentially undervalued stock. However, a 73% dividend payout on modest earnings raises concerns about sustainability, and the 95% 30‑day volatility combined with decreasing volume adds to the risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Bullish MACD histogram indicating potential near‑term bounce
  • High 30‑day volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E far below industry average
  • Significant upside potential toward 240,000 KRW
  • Attractive dividend yield despite sustainability concerns

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Heavy debt burden and low profitability
  • Diversified conglomerate structure providing resilience
  • Dividend payout ratio may pressure cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth8.00%
Profit Margin0.33%
P/E Ratio9.1
ROE1.06%
ROA3.19%
Debt/Equity115.22
Op. Cash Flow₩4748.0B
Free Cash Flow₩110.2B
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI44.9
Support₩159,300.00
Resistance₩232,500.00
MA 20₩177,350.00
MA 50₩195,726.00
MA 200₩186,532.00
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target Price₩240,000.00
Upside/Downside37.54%
GradeUndervalued
TypeValue
Dividend Yield1.89%

Risk Assessment

Beta0.70
Volatility95.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.